Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Braakman

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Clinical and Experimental Immunology|February 1, 1988
Role of IL-2 and interferon in the generation of natural cytotoxic activity in influenza virus-stimulated PBL cultures: analysis with the use of prednisoloneE Braakman, P Treep-van Leeuwen, R J ten Berge, et al.
Cellular Immunology|August 1, 1992
CD16 on human gamma delta T lymphocytes: expression, function, and specificity for mouse IgG isotypesE Braakman, J G van de Winkel, B A van Krimpen, et al.
International Immunology|July 1, 1991
Expression of CD45 isoforms by fresh and activated human gamma delta T lymphocytes and natural killer cellsE Braakman, E Sturm, K Vijverberg, et al.
International Journal of Cancer|September 15, 1990
ICAM- melanoma cells are relatively resistant to CD3-mediated T-cell lysisE Braakman, P S Goedegebuure, R J Vreugdenhil, et al.
Gene|November 30, 1998
Second gene expression in bicistronic constructs using short synthetic intercistrons and viral IRES sequencesM J Havenga, R Vogels, E Braakman, et al.
Bone Marrow Transplantation|May 29, 1998
Influence of ultraviolet-B irradiation on engraftment, graft-versus-host disease and graft-versus-leukemia effect in a rat model for allogeneic bone marrow transplantationH Gowing, E Braakman, A Hagenbeek, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1990
Interleukin-2. The experience of the Rotterdam Cancer Institute; Daniel den Hoed KliniekG Stoter, S H Goey, A M Eggermont, et al.
European Journal of Immunology|January 1, 1992
Genetic correction of cultured T cells from an adenosine deaminase-deficient patient: characteristics of non-transduced and transduced T cellsE Braakman, V W Van Beusechem, B A Van Krimpen, et al.
Clinical and Experimental Immunology|May 1, 1993
Activation of the immune system of cancer patients by continuous i.v. recombinant IL-2 (rIL-2) therapy is dependent on dose and schedule of rIL-2J W Gratama, R J Bruin, C H Lamers, et al.
Gene Therapy|August 24, 1999
Ganciclovir-mediated in vivo elimination of myeloid leukemic cells expressing the HSVtk gene induces HSVtk loss variantsE Braakman, R Vogels, A C Martens, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Clinical and Experimental Immunology|February 1, 1988
Role of IL-2 and interferon in the generation of natural cytotoxic activity in influenza virus-stimulated PBL cultures: analysis with the use of prednisoloneE Braakman, P Treep-van Leeuwen, R J ten Berge, et al.
Cellular Immunology|August 1, 1992
CD16 on human gamma delta T lymphocytes: expression, function, and specificity for mouse IgG isotypesE Braakman, J G van de Winkel, B A van Krimpen, et al.
International Immunology|July 1, 1991
Expression of CD45 isoforms by fresh and activated human gamma delta T lymphocytes and natural killer cellsE Braakman, E Sturm, K Vijverberg, et al.
International Journal of Cancer|September 15, 1990
ICAM- melanoma cells are relatively resistant to CD3-mediated T-cell lysisE Braakman, P S Goedegebuure, R J Vreugdenhil, et al.
Gene|November 30, 1998
Second gene expression in bicistronic constructs using short synthetic intercistrons and viral IRES sequencesM J Havenga, R Vogels, E Braakman, et al.
Bone Marrow Transplantation|May 29, 1998
Influence of ultraviolet-B irradiation on engraftment, graft-versus-host disease and graft-versus-leukemia effect in a rat model for allogeneic bone marrow transplantationH Gowing, E Braakman, A Hagenbeek, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1990
Interleukin-2. The experience of the Rotterdam Cancer Institute; Daniel den Hoed KliniekG Stoter, S H Goey, A M Eggermont, et al.
European Journal of Immunology|January 1, 1992
Genetic correction of cultured T cells from an adenosine deaminase-deficient patient: characteristics of non-transduced and transduced T cellsE Braakman, V W Van Beusechem, B A Van Krimpen, et al.
Clinical and Experimental Immunology|May 1, 1993
Activation of the immune system of cancer patients by continuous i.v. recombinant IL-2 (rIL-2) therapy is dependent on dose and schedule of rIL-2J W Gratama, R J Bruin, C H Lamers, et al.
Gene Therapy|August 24, 1999
Ganciclovir-mediated in vivo elimination of myeloid leukemic cells expressing the HSVtk gene induces HSVtk loss variantsE Braakman, R Vogels, A C Martens, et al.
Pageof 4